Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Key Players companies in Peripheral neuropathy
by Highest Patent Value in the Switzerland in 2019

The Peripheral neuropathy top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Peripheral neuropathy Key Players in the Switzerland. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
A disease affecting peripheral nerves.
#
Company Name
Region
Tech Topics
Total
1
F. Hoffmann-La Roche Ltd.
Medicine,Health care,Drug,
...[+2]
Avg patent value: 6.99 M
2
Baxalta GmbH
Drug,Medicine
Avg patent value: 6.94 M
3
Baxter Healthcare SA
Healthcare system,Medicine
Avg patent value: 6.94 M
4
Volution Immuno Pharmaceuticals SA
Anti-inflammatory,Medicine
Avg patent value: 2.47 M
5
Novartis AG
Dosage form,Health care,Medicine,
...[+2]
Avg patent value: 1.57 M
6
Metys Pharmaceuticals AG
Chemotherapy-induced peripheral neuropathy,Dimiracetam,Medical equipment,
...[+2]
Avg patent value: 390,185
7
Nestlé SA
Ice cream,Nutrition,Cosmetics,
...[+2]
Avg patent value: 100,000
8
Nestec SA
Enzyme,Nutrition,Food industry,
...[+1]
Avg patent value: 100,000
9
Sandoz AG
Botanical drug,Herb
Avg patent value: 0
10
Neurotune AG
Medicine,Neuroscience,Health care,
...[+2]
Avg patent value: 0
Page generation time: Jul 22 2025